Page values for "Rizatriptan"
Appearance
"Medicines" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| generic | String | Rizatriptan (benzoate) |
| brand | String | Maxalt (tablet), Maxalt-MLT (orally disintegrating tablet) |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:Triptans|Triptan (5-HT1B/1D agonist)]] • [[:Category:Antimigraine medicines|Antimigraine medicine]] • [[:Category:Analgesics|Analgesic]] |
| mechanism | String | |
| uses | String | '"`UNIQ--vote-00000011-QINU`"' |
| starting_dose | String | 5-10 mg PO at migraine onset; may repeat after 2 hours, maximum 30 mg/24 hours |
| preparations | String | Tablets 5, 10 mg; ODT (Maxalt-MLT) 5, 10 mg |
| fda_max | String | 30 mg/24 hours |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral |
| onset | String | 30 minutes for migraine relief |
| duration | String | 4-6 hours; headache recurrence is common |
| halflife | String | 2-3 hours'"`UNIQ--ref-00000012-QINU`"' |
| bioavailability | String | ~45% (oral; substantially higher than sumatriptan's ~14%)'"`UNIQ--ref-00000013-QINU`"' |
| pregnancy | String | Limited human data; pregnancy registry data have been broadly reassuring across the triptan class.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | [[USLegal:Prescription only|Rx-only]] in US |